Showing results (21-30 of 136) with videos related to
Sort By:
Pageof 14
Frontiers in Oncology|August 17, 2019
Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic CancersTze-Sian Chan, Yuval Shaked, Kelvin K TsaiJournal of Clinical Medicine|May 22, 2019
Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical SetbacksKelvin K Tsai, Tze-Sian Chan, Yuval ShakedJournal of Clinical Medicine|December 5, 2020
The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor MicroenvironmentAvital Vorontsova, Tal Kan, Ziv Raviv, et al.Drug Discovery Today|August 8, 2012
Low-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancerDavid Loven, Erez Hasnis, Francesco Bertolini, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 25, 2009
Metronomic chemotherapy: principles and lessons learned from applications in the treatment of metastatic prostate cancerUrban Emmenegger, Giulio Francia, Yuval Shaked, et al.Drug Discovery Today|October 16, 2007
Molecular and cellular biomarkers for angiogenesis in clinical oncologyFrancesco Bertolini, Patrizia Mancuso, Yuval Shaked, et al.Nature Reviews. Cancer|October 13, 2006
The multifaceted circulating endothelial cell in cancer: towards marker and target identificationFrancesco Bertolini, Yuval Shaked, Patrizia Mancuso, et al.Brain Research|December 4, 2003
Copper binding to PrPC may inhibit prion disease propagationNuha Hijazi, Yuval Shaked, Hana Rosenmann, et al.Biochimica Et Biophysica Acta|May 2, 2009
The multiple personality disorder phenotype(s) of circulating endothelial cells in cancerFrancesco Bertolini, Patrizia Mancuso, Paola Braidotti, et al.Methods in Molecular Biology (Clifton, N.J.)|August 15, 2012
Evaluation of circulating endothelial precursor cells in cancer patientsFrancesco Bertolini, Patrizia Mancuso, Liat Benayoun, et al.Pageof 14